Related Experiment Video
Updated: Mar 29, 2026

Enhanced Oil Recovery using a Combination of Biosurfactants
Published on: June 3, 2022
Antibacterial properties of biosurfactants against selected Gram-positive and -negative bacteria
Mayri A Díaz De Rienzo1, Paul Stevenson2, Roger Marchant3
1School of Chemical Engineering and Analytical Science, University of Manchester, Manchester, M13 9PL, UK.
Abstract:
The antibacterial properties and ability to disrupt biofilms of biosurfactants (rhamnolipids, sophorolipids) and sodium dodecyl sulphate (SDS) in the presence and absence of selected organic acids were investigated. Pseudomonas aeruginosa PAO1 was inhibited by sophorolipids and SDS at concentrations >5% v/v, and the growth of Escherichia coli NCTC 10418 was also inhibited by sophorolipids and SDS at concentrations >5% and 0.1% v/v, respectively. Bacillus subtilis NCTC 10400 was inhibited by rhamnolipids, sophorolipids and SDS at concentrations >0.5% v/v of all three; the same effect was observed with Staphylococcus aureus ATCC 9144. The ability to attach to surfaces and biofilm formation of P. aeruginosa PAO1, E. coli NCTC 10418 and B. subtilis NCTC 10400 was inhibited by sophorolipids (1% v/v) in the presence of caprylic acid (0.8% v/v). In the case of S. aureus ATCC 9144, the best results were obtained using caprylic acid on its own. It was concluded that sophorolipids are promising compounds for the inhibition/disruption of biofilms formed by Gram-positive and Gram-negative microorganisms and this activity can be enhanced by the presence of booster compounds such as caprylic acid.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Biological Methods for Microbial Control
Bacterial Cell Wall
Clinical Significance of Antibiotic Resistance
Surface Active Agents

